360 Capital Group (ASX:TGP) Announces Off-Market Buy-Back
360 Capital Group (ASX:TGP) announces an off-market buy-back of up to 15.4% of its securities at $0.65 per security.
Category: Companies
Hancock & Gore Limited (ASX:HNG) Announces H1 FY25 Trading Update
Hancock & Gore Limited (ASX:HNG) reports a 3% sales increase in H1 FY25 and announces a forthcoming dividend declaration.
Helios Energy Ltd (ASX:HE8) Announces Results of Entitlement Offer
Helios Energy Ltd (ASX:HE8) completes its entitlement offer, successfully raising $2.6 million to advance the Presidio Project.
Pro Medicus Limited (ASX:PME) Signs Multi-Year Research Collaboration with UCSF
Pro Medicus Limited (ASX:PME) enters a multi-year AI research collaboration with UCSF to advance healthcare imaging solutions.
EBR Systems (ASX:EBR) Secures NTAP Reimbursement Approval
EBR Systems (ASX:EBR) proposes CMS approval of NTAP reimbursement for its WiSE CRT System, advancing US market strategy.
The Star Entertainment Group (ASX:SGR) Announces H1 FY25 Results
The Star Entertainment Group (ASX:SGR) reports H1 FY25 results, highlighting revenue decline and strategic investment initiatives.
Fenix Resources Limited (ASX:FEX) Announces Q1 2025 Quarterly Report and CZR Acquisition Offer
Fenix Resources (ASX:FEX) reports record Q1 2025 iron ore shipments and initiates takeover offer for CZR Resources.
Swift Networks Group Ltd (ASX:SW1) Secures $820,800 Subscription Deal with Newmont Mining
Swift Networks Group Ltd (ASX:SW1) secures a $820,800 subscription agreement with Newmont Mining for Swift Access at Tanami.
Aurumin Limited (ASX:AUN) Completes Gwendolyn Drilling Program
Aurumin Limited (ASX:AUN) completes RC drilling at Gwendolyn deposit, advancing near-term development with results expected mid-May.
Clarity Pharmaceuticals (ASX:CU6) Treats First Patient in Phase II SECuRE Trial
Clarity Pharmaceuticals (ASX:CU6) begins Phase II SECuRE trial with first patient treated and enhances 67Cu-SAR-bisPSMA formulation.